 | • レポートコード：MRC308GR11366 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の抗呼吸器合胞体（RS)ウイルス薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の抗呼吸器合胞体（RS)ウイルス薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 抗呼吸器合胞体（RS)ウイルス薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
抗呼吸器合胞体（RS)ウイルス薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・小児用医薬品、成人用医薬品
用途別セグメント
・病院、ドラッグストア、その他
主要な市場プレーヤー
・AstraZeneca、Sanofi、Janssen Pharmaceutica、Merck、Enanta Pharma、Pfizer、GSK、Shanghai Ark Biopharmaceutical、Walvax Biotechnology
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、抗呼吸器合胞体（RS)ウイルス薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な抗呼吸器合胞体（RS)ウイルス薬メーカーの企業概要、2019年～2022年までの抗呼吸器合胞体（RS)ウイルス薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な抗呼吸器合胞体（RS)ウイルス薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別抗呼吸器合胞体（RS)ウイルス薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの抗呼吸器合胞体（RS)ウイルス薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での抗呼吸器合胞体（RS)ウイルス薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および抗呼吸器合胞体（RS)ウイルス薬の産業チェーンを掲載しています。
・第14、15章では、抗呼吸器合胞体（RS)ウイルス薬の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 抗呼吸器合胞体（RS)ウイルス薬の概要
– 種類別分析（2018年vs2022年vs2029年）：小児用医薬品、成人用医薬品
– 用途別分析（2018年vs2022年vs2029年）：病院、ドラッグストア、その他
– 世界の抗呼吸器合胞体（RS)ウイルス薬市場規模・予測
– 世界の抗呼吸器合胞体（RS)ウイルス薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– AstraZeneca、Sanofi、Janssen Pharmaceutica、Merck、Enanta Pharma、Pfizer、GSK、Shanghai Ark Biopharmaceutical、Walvax Biotechnology
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：小児用医薬品、成人用医薬品
・用途別分析2018年-2029年：病院、ドラッグストア、その他
・抗呼吸器合胞体（RS)ウイルス薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・抗呼吸器合胞体（RS)ウイルス薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・抗呼吸器合胞体（RS)ウイルス薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・抗呼吸器合胞体（RS)ウイルス薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・抗呼吸器合胞体（RS)ウイルス薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Anti-Respiratory Syncytial Virus Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Child Drug
1.3.3 Aldult Drug
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Drugstores
1.4.4 Others
1.5 Global Anti-Respiratory Syncytial Virus Drugs Market Size & Forecast
1.5.1 Global Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity (2018-2029)
1.5.3 Global Anti-Respiratory Syncytial Virus Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Anti-Respiratory Syncytial Virus Drugs Product and Services
2.1.4 AstraZeneca Anti-Respiratory Syncytial Virus Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Anti-Respiratory Syncytial Virus Drugs Product and Services
2.2.4 Sanofi Anti-Respiratory Syncytial Virus Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 Janssen Pharmaceutica
2.3.1 Janssen Pharmaceutica Details
2.3.2 Janssen Pharmaceutica Major Business
2.3.3 Janssen Pharmaceutica Anti-Respiratory Syncytial Virus Drugs Product and Services
2.3.4 Janssen Pharmaceutica Anti-Respiratory Syncytial Virus Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Janssen Pharmaceutica Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Anti-Respiratory Syncytial Virus Drugs Product and Services
2.4.4 Merck Anti-Respiratory Syncytial Virus Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck Recent Developments/Updates
2.5 Enanta Pharma
2.5.1 Enanta Pharma Details
2.5.2 Enanta Pharma Major Business
2.5.3 Enanta Pharma Anti-Respiratory Syncytial Virus Drugs Product and Services
2.5.4 Enanta Pharma Anti-Respiratory Syncytial Virus Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Enanta Pharma Recent Developments/Updates
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Anti-Respiratory Syncytial Virus Drugs Product and Services
2.6.4 Pfizer Anti-Respiratory Syncytial Virus Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Recent Developments/Updates
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business
2.7.3 GSK Anti-Respiratory Syncytial Virus Drugs Product and Services
2.7.4 GSK Anti-Respiratory Syncytial Virus Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GSK Recent Developments/Updates
2.8 Shanghai Ark Biopharmaceutical
2.8.1 Shanghai Ark Biopharmaceutical Details
2.8.2 Shanghai Ark Biopharmaceutical Major Business
2.8.3 Shanghai Ark Biopharmaceutical Anti-Respiratory Syncytial Virus Drugs Product and Services
2.8.4 Shanghai Ark Biopharmaceutical Anti-Respiratory Syncytial Virus Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Shanghai Ark Biopharmaceutical Recent Developments/Updates
2.9 Walvax Biotechnology
2.9.1 Walvax Biotechnology Details
2.9.2 Walvax Biotechnology Major Business
2.9.3 Walvax Biotechnology Anti-Respiratory Syncytial Virus Drugs Product and Services
2.9.4 Walvax Biotechnology Anti-Respiratory Syncytial Virus Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Walvax Biotechnology Recent Developments/Updates
3 Competitive Environment: Anti-Respiratory Syncytial Virus Drugs by Manufacturer
3.1 Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-Respiratory Syncytial Virus Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Anti-Respiratory Syncytial Virus Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-Respiratory Syncytial Virus Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-Respiratory Syncytial Virus Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-Respiratory Syncytial Virus Drugs Manufacturer Market Share in 2022
3.5 Anti-Respiratory Syncytial Virus Drugs Market: Overall Company Footprint Analysis
3.5.1 Anti-Respiratory Syncytial Virus Drugs Market: Region Footprint
3.5.2 Anti-Respiratory Syncytial Virus Drugs Market: Company Product Type Footprint
3.5.3 Anti-Respiratory Syncytial Virus Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anti-Respiratory Syncytial Virus Drugs Market Size by Region
4.1.1 Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Anti-Respiratory Syncytial Virus Drugs Average Price by Region (2018-2029)
4.2 North America Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018-2029)
4.3 Europe Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018-2029)
4.5 South America Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2029)
5.2 Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Type (2018-2029)
5.3 Global Anti-Respiratory Syncytial Virus Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2029)
6.2 Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Application (2018-2029)
6.3 Global Anti-Respiratory Syncytial Virus Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2029)
7.2 North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2029)
7.3 North America Anti-Respiratory Syncytial Virus Drugs Market Size by Country
7.3.1 North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-Respiratory Syncytial Virus Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Anti-Respiratory Syncytial Virus Drugs Market Size by Country
8.3.1 Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-Respiratory Syncytial Virus Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Market Size by Region
9.3.1 Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2029)
10.2 South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2029)
10.3 South America Anti-Respiratory Syncytial Virus Drugs Market Size by Country
10.3.1 South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-Respiratory Syncytial Virus Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Market Size by Country
11.3.1 Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anti-Respiratory Syncytial Virus Drugs Market Drivers
12.2 Anti-Respiratory Syncytial Virus Drugs Market Restraints
12.3 Anti-Respiratory Syncytial Virus Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anti-Respiratory Syncytial Virus Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-Respiratory Syncytial Virus Drugs
13.3 Anti-Respiratory Syncytial Virus Drugs Production Process
13.4 Anti-Respiratory Syncytial Virus Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-Respiratory Syncytial Virus Drugs Typical Distributors
14.3 Anti-Respiratory Syncytial Virus Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Anti-Respiratory Syncytial Virus Drugs Product and Services
Table 6. AstraZeneca Anti-Respiratory Syncytial Virus Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Anti-Respiratory Syncytial Virus Drugs Product and Services
Table 11. Sanofi Anti-Respiratory Syncytial Virus Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. Janssen Pharmaceutica Basic Information, Manufacturing Base and Competitors
Table 14. Janssen Pharmaceutica Major Business
Table 15. Janssen Pharmaceutica Anti-Respiratory Syncytial Virus Drugs Product and Services
Table 16. Janssen Pharmaceutica Anti-Respiratory Syncytial Virus Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Janssen Pharmaceutica Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck Anti-Respiratory Syncytial Virus Drugs Product and Services
Table 21. Merck Anti-Respiratory Syncytial Virus Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck Recent Developments/Updates
Table 23. Enanta Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Enanta Pharma Major Business
Table 25. Enanta Pharma Anti-Respiratory Syncytial Virus Drugs Product and Services
Table 26. Enanta Pharma Anti-Respiratory Syncytial Virus Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Enanta Pharma Recent Developments/Updates
Table 28. Pfizer Basic Information, Manufacturing Base and Competitors
Table 29. Pfizer Major Business
Table 30. Pfizer Anti-Respiratory Syncytial Virus Drugs Product and Services
Table 31. Pfizer Anti-Respiratory Syncytial Virus Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Pfizer Recent Developments/Updates
Table 33. GSK Basic Information, Manufacturing Base and Competitors
Table 34. GSK Major Business
Table 35. GSK Anti-Respiratory Syncytial Virus Drugs Product and Services
Table 36. GSK Anti-Respiratory Syncytial Virus Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. GSK Recent Developments/Updates
Table 38. Shanghai Ark Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Shanghai Ark Biopharmaceutical Major Business
Table 40. Shanghai Ark Biopharmaceutical Anti-Respiratory Syncytial Virus Drugs Product and Services
Table 41. Shanghai Ark Biopharmaceutical Anti-Respiratory Syncytial Virus Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Shanghai Ark Biopharmaceutical Recent Developments/Updates
Table 43. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 44. Walvax Biotechnology Major Business
Table 45. Walvax Biotechnology Anti-Respiratory Syncytial Virus Drugs Product and Services
Table 46. Walvax Biotechnology Anti-Respiratory Syncytial Virus Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Walvax Biotechnology Recent Developments/Updates
Table 48. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Anti-Respiratory Syncytial Virus Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Anti-Respiratory Syncytial Virus Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in Anti-Respiratory Syncytial Virus Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Anti-Respiratory Syncytial Virus Drugs Production Site of Key Manufacturer
Table 53. Anti-Respiratory Syncytial Virus Drugs Market: Company Product Type Footprint
Table 54. Anti-Respiratory Syncytial Virus Drugs Market: Company Product Application Footprint
Table 55. Anti-Respiratory Syncytial Virus Drugs New Market Entrants and Barriers to Market Entry
Table 56. Anti-Respiratory Syncytial Virus Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Anti-Respiratory Syncytial Virus Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global Anti-Respiratory Syncytial Virus Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Anti-Respiratory Syncytial Virus Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global Anti-Respiratory Syncytial Virus Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Anti-Respiratory Syncytial Virus Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global Anti-Respiratory Syncytial Virus Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Anti-Respiratory Syncytial Virus Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Anti-Respiratory Syncytial Virus Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Anti-Respiratory Syncytial Virus Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Anti-Respiratory Syncytial Virus Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Anti-Respiratory Syncytial Virus Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Anti-Respiratory Syncytial Virus Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Anti-Respiratory Syncytial Virus Drugs Raw Material
Table 116. Key Manufacturers of Anti-Respiratory Syncytial Virus Drugs Raw Materials
Table 117. Anti-Respiratory Syncytial Virus Drugs Typical Distributors
Table 118. Anti-Respiratory Syncytial Virus Drugs Typical Customers
List of Figures
Figure 1. Anti-Respiratory Syncytial Virus Drugs Picture
Figure 2. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Type in 2022
Figure 4. Child Drug Examples
Figure 5. Aldult Drug Examples
Figure 6. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Application in 2022
Figure 8. Hospitals Examples
Figure 9. Drugstores Examples
Figure 10. Others Examples
Figure 11. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Anti-Respiratory Syncytial Virus Drugs Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Anti-Respiratory Syncytial Virus Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Anti-Respiratory Syncytial Virus Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Anti-Respiratory Syncytial Virus Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Anti-Respiratory Syncytial Virus Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Anti-Respiratory Syncytial Virus Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Region (2018-2029)
Figure 53. China Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Anti-Respiratory Syncytial Virus Drugs Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Anti-Respiratory Syncytial Virus Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Anti-Respiratory Syncytial Virus Drugs Market Drivers
Figure 74. Anti-Respiratory Syncytial Virus Drugs Market Restraints
Figure 75. Anti-Respiratory Syncytial Virus Drugs Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Anti-Respiratory Syncytial Virus Drugs in 2022
Figure 78. Manufacturing Process Analysis of Anti-Respiratory Syncytial Virus Drugs
Figure 79. Anti-Respiratory Syncytial Virus Drugs Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source